<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28594402</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Jun</Month><Day>08</Day></PubDate></JournalIssue><Title>Cell death &amp; disease</Title><ISOAbbreviation>Cell Death Dis</ISOAbbreviation></Journal><ArticleTitle>ARRDC4 regulates enterovirus 71-induced innate immune response by promoting K63 polyubiquitination of MDA5 through TRIM65.</ArticleTitle><Pagination><StartPage>e2866</StartPage><MedlinePgn>e2866</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/cddis.2017.257</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is the main causative agent of hand, foot and mouth disease (HFMD), which induces significantly elevated levels of cytokines and chemokines, leading to local or system inflammation and severe complications, whereas the underlying regulatory mechanisms and the inflammatory pathogenesis remain elusive. ARRDC4 is one member of arrestins family, having important roles in glucose metabolism and G-protein-coupled receptors (GPCRs) related physiological and pathological processes, however, the function of ARRDC4 in innate immune system is largely unknown. Here we identified that ARRDC4 expression was increased after EV71 infection in THP-1-derived macrophages and verified in EV71-infected HFMD patients and the healthy candidates. The expression level of ARRDC4 was positively correlated with the serum concentration of IL-6, TNF-&#x3b1; and CCL3 in clinical specimens. ARRDC4 interacted with MDA5 via the arrestin-like N domain, and further recruited TRIM65 to enhance the K63 ubiquitination of MDA5, resulting in activation of the downstream innate signaling pathway and transcription of proinflammatory cytokines during EV71 infection. Our data highlight new function of ARRDC4 in innate immunity, contributing to the better understanding about regulation of MDA5 activation after EV71 infection, and also suggest ARRDC4 may serve as a potential target for intervention of EV71-induced inflammatory response.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Occupational and Environmental Health Key Laboratory of Environment and Health, Ministry of Education and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Zhenyu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Translational Medicine R&amp;D Center, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Yaqing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Renli</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yanwei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Xiangjie</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Long</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hailong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Xueqin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology, College of Public Health, Sun Yat-Sen University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Tangchun</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Occupational and Environmental Health Key Laboratory of Environment and Health, Ministry of Education and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Jinquan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Dis</MedlineTA><NlmUniqueID>101524092</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000070584">Tripartite Motif Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="C000591243">TRIM6 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C452815">IFIH1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D000072640">Interferon-Induced Helicase, IFIH1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="Y">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072640" MajorTopicYN="N">Interferon-Induced Helicase, IFIH1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074084" MajorTopicYN="N">THP-1 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070584" MajorTopicYN="N">Tripartite Motif Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="N">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054875" MajorTopicYN="N">Ubiquitination</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28594402</ArticleId><ArticleId IdType="pmc">PMC5520913</ArticleId><ArticleId IdType="doi">10.1038/cddis.2017.257</ArticleId><ArticleId IdType="pii">cddis2017257</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 2010; 10: 778&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Yu CK, Wang JR, Su IJ, Liu CC. Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. J Infect Dis 2008; 198: 1002&#x2013;1006.</Citation><ArticleIdList><ArticleId IdType="pubmed">18710325</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, Foo DG, Trasti SL, Tan EL, Alonso S. Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model. J Virol 2011; 85: 3067&#x2013;3076.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3067852</ArticleId><ArticleId IdType="pubmed">21228224</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ML, Lee YP, Wang YF, Lei HY, Liu CC, Wang SM et al. Type I interferons protect mice against enterovirus 71 infection. J Gen Virol 2005; 86: 3263&#x2013;3269.</Citation><ArticleIdList><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Yi L, Zhao J, Yu J, Chen Y, Lin MC et al. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J Virol 2012; 86: 3767&#x2013;3776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X. Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease. Nat Rev Immunol 2016; 16: 35&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">26711677</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5: 730&#x2013;737.</Citation><ArticleIdList><ArticleId IdType="pubmed">15208624</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, Matsushita K et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 2008; 205: 1601&#x2013;1610.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2442638</ArticleId><ArticleId IdType="pubmed">18591409</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 2006; 103: 8459&#x2013;8464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1464000</ArticleId><ArticleId IdType="pubmed">16714379</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441: 101&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">16625202</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Chen ZJ. Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol 2014; 32: 461&#x2013;488.</Citation><ArticleIdList><ArticleId IdType="pubmed">24655297</ArticleId></ArticleIdList></Reference><Reference><Citation>Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007; 446: 916&#x2013;920.</Citation><ArticleIdList><ArticleId IdType="pubmed">17392790</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshiumi H, Miyashita M, Inoue N, Okabe M, Matsumoto M, Seya T. The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe 2010; 8: 496&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pubmed">21147464</ArticleId></ArticleIdList></Reference><Reference><Citation>Arimoto K, Takahashi H, Hishiki T, Konishi H, Fujita T, Shimotohno K. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci USA 2007; 104: 7500&#x2013;7505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1863485</ArticleId><ArticleId IdType="pubmed">17460044</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuniyoshi K, Takeuchi O, Pandey S, Satoh T, Iwasaki H, Akira S et al. Pivotal role of RNA-binding E3 ubiquitin ligase MEX3C in RIG-I-mediated antiviral innate immunity. Proc Natl Acad Sci USA 2014; 111: 5646&#x2013;5651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3992669</ArticleId><ArticleId IdType="pubmed">24706898</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman CS, O'Donnell MA, Legarda-Addison D, Ng A, Cardenas WB, Yount JS et al. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep 2008; 9: 930&#x2013;936.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2529351</ArticleId><ArticleId IdType="pubmed">18636086</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Han C, Xie B, Hu X, Yu Q, Shi L et al. Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation. Cell 2013; 152: 467&#x2013;478.</Citation><ArticleIdList><ArticleId IdType="pubmed">23374343</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui J, Zhu L, Xia X, Wang HY, Legras X, Hong J et al. NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell 2010; 141: 483&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3150216</ArticleId><ArticleId IdType="pubmed">20434986</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez CE. On the origins of arrestin and rhodopsin. BMC Evol Biol 2008; 8: 222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2515105</ArticleId><ArticleId IdType="pubmed">18664266</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang D, Xie T, Liang J, Noble PW. beta-Arrestins in the immune system. Prog Mol Biol Transl Sci 2013; 118: 359&#x2013;393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4467910</ArticleId><ArticleId IdType="pubmed">23764061</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Tang Y, Teng L, Wu Y, Zhao X, Pei G. Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 2006; 7: 139&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">16378096</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo W, Zhang L, Yang G, Zhai J, Hu Z, Chen Y et al. Nuclear beta-arrestin1 functions as a scaffold for the dephosphorylation of STAT1 and moderates the antiviral activity of IFN-gamma. Mol Cell 2008; 31: 695&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pubmed">18775329</ArticleId></ArticleIdList></Reference><Reference><Citation>Patwari P, Chutkow WA, Cummings K, Verstraeten VL, Lammerding J, Schreiter ER et al. Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins. J Biol Chem 2009; 284: 24996&#x2013;25003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2757204</ArticleId><ArticleId IdType="pubmed">19605364</ArticleId></ArticleIdList></Reference><Reference><Citation>Becuwe M, Herrador A, Haguenauer-Tsapis R, Vincent O, Leon S. Ubiquitin-mediated regulation of endocytosis by proteins of the arrestin family. Biochem Res Int 2012; 2012: 242764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3439951</ArticleId><ArticleId IdType="pubmed">22988512</ArticleId></ArticleIdList></Reference><Reference><Citation>Shea FF, Rowell JL, Li Y, Chang TH, Alvarez CE. Mammalian alpha arrestins link activated seven transmembrane receptors to Nedd4 family e3 ubiquitin ligases and interact with beta arrestins. PLoS ONE 2012; 7: e50557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3517545</ArticleId><ArticleId IdType="pubmed">23236378</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Cui S, Zhao Z, Wang J. Etiology, pathogenesis, antivirals and vaccines of hand,foot, and mouth disease. Natl Sci Rev 2015; 2: 268&#x2013;284.</Citation></Reference><Reference><Citation>Carpenter S, Wochal P, Dunne A, O'Neill LA. Toll-like receptor 3 (TLR3) signaling requires TLR4 interactor with leucine-rich REPeats (TRIL). J Biol Chem 2011; 286: 38795&#x2013;38804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3207441</ArticleId><ArticleId IdType="pubmed">21911501</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang X, Tang T, Jin T, Ding C, Zhou R, Jiang W. TRIM65-catalized ubiquitination is essential for MDA5-mediated antiviral innate immunity. J Exp Med 2017; 214: 459&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5294850</ArticleId><ArticleId IdType="pubmed">28031478</ArticleId></ArticleIdList></Reference><Reference><Citation>Han SO, Kommaddi RP, Shenoy SK. Distinct roles for beta-arrestin2 and arrestin-domain-containing proteins in beta2 adrenergic receptor trafficking. EMBO Rep 2013; 14: 164&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3596129</ArticleId><ArticleId IdType="pubmed">23208550</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaadige MR, Looper RE, Kamalanaadhan S, Ayer DE. Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity. Proc Natl Acad Sci USA 2009; 106: 14878&#x2013;14883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2736411</ArticleId><ArticleId IdType="pubmed">19706488</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang X, Kinch LN, Brautigam CA, Chen X, Du F, Grishin NV et al. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity 2012; 36: 959&#x2013;973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3412146</ArticleId><ArticleId IdType="pubmed">22705106</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayan K, Waggoner L, Pham ST, Hendricks GL, Waggoner SN, Conlon J et al. TRIM13 is a negative regulator of MDA5-mediated type I interferon production. J Virol 2014; 88: 10748&#x2013;10757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4178852</ArticleId><ArticleId IdType="pubmed">25008915</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Yang YK, Chen T, Zhang H, Yang WW, Song SS et al. RNF123 has an E3 ligase-independent function in RIG-I-like receptor-mediated antiviral signaling. EMBO Rep 2016; 17: 1155&#x2013;1168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4967948</ArticleId><ArticleId IdType="pubmed">27312109</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsou YL, Lin YW, Shao HY, Yu SL, Wu SR, Lin HY et al. Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease. PLoS Negl Trop Dis 2015; 9: e0003692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4391779</ArticleId><ArticleId IdType="pubmed">25855976</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Langereis MA, Lork M, Nguyen M, Hato SV, Lanke K et al. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J Virol 2014; 88: 3369&#x2013;3378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Liu X, Ma Y, Sun Z, Yang Y, Jin Q et al. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J Virol 2010; 84: 8051&#x2013;8061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Xiao X, Xue Q, Jin Q, He B, Wang J. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J Virol 2013; 87: 1690&#x2013;1698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung HC, Wang HC, Shih SR, Teng IF, Tseng CP, Hsu JT. Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir. J Infect Dis 2011; 203: 1784&#x2013;1790.</Citation><ArticleIdList><ArticleId IdType="pubmed">21536800</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng J, Liu X, Zhang P, Li D, Xu S, Zhou Q et al. Rb selectively inhibits innate IFN-beta production by enhancing deacetylation of IFN-beta promoter through HDAC1 and HDAC8. J Autoimmun 2016; 73: 42&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">27267461</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>